Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

LIXTLIXT
Showing 8 of 17 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in LIXTE BIOTECHNOLOGY HLDGS IN

GEODE CAPITAL MANAGEMENT, LLC holds 143,036 shares of LIXT (LIXTE BIOTECHNOLOGY HLDGS IN), worth $1.1M as of 2026-Q2. The position was increased (+143.0% shares). LIXT represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$1.1M

Current Shares

143,036

Total Value Change

+$1M

Total Shares Change

+125,875

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
143,036
+143.0%
$1.1M0.0%$7.42
41
2026-Q1
Increased
58,852
+12.8%
$180,6750.0%$2.85
17
2025-Q4
Increased
52,163
+25.9%
$204,9990.0%$3.90
19
2025-Q3
Increased
41,441
+100.2%
$208,4470.0%$5.19
25
2025-Q2
Decreased
20,704
-10.1%
$18,7010.0%$0.71
0
2025-Q1
Increased
23,041
+36.6%
$27,8790.0%$1.27
17
2024-Q4
Decreased
16,866
-1.7%
$35,4180.0%$2.00
0
2024-Q3
New
17,161
-
$33,4630.0%$1.91
30

Other major holders of LIXT: VANGUARD CAPITAL MANAGEMENT LLC, SCOTIA CAPITAL INC., EP Wealth Advisors, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used